AccuDial to roll out dosing system
PALM BEACH GARDENS, Fla. AccuDial Pharmaceutical recently shared plans to launch its line of patented dosing systems in the United States this fall. The system features an accurate dosing spoon, coupled with weight-based dosing recommendations, as opposed to age-based dosing recommendations found on many kids’ product labels today.
The August/September launch will start with its liquid acetaminophen line and is expected to expand from there. Retailing for a suggested $6.99, Children’s Accudial will be supported with a $15 million print media campaign.
AccuDial Pharmaceutical’s AccuDial product was featured in January on an episode of CBS’ “The Doctors” as one solution to dosing concerns facing parents.
“Studies show that children are given an inaccurate dose of over-the-counter medication more than half the time by parents,” said Dr. Jim Sears, a board certified pediatrician and one of the featured doctors on the program. “Pediatricians, we always dose by weight,” he said. “But a lot of the over-the-counter [medicines] give an age range — 6 to 12 years old — a huge range.”
Sears then held an AccuDial label up to the camera, explaining that the patented label could be rotated so that parents could determine proper dosage by weight.
Bausch & Lomb recruits two Schering-Plough leaders as CEO, chairman
ROCHESTER, N.Y. Bausch & Lomb on Monday recruited two former Schering-Plough senior leaders to take the reigns at the eye care company.
Former Schering-Plough chairman and CEO Fred Hassan will now serve as B&L chairman, and Brent Saunders, most recently SVP and president of Schering-Plough’s Consumer Healthcare unit, was named CEO. The moves are effective immediately.
B&L’s current chairman and CEO Gerald Ostrov is retiring and will serve as a consultant during the transition, B&L stated.
“Jerry Ostrov stabilized a very challenging situation at Bausch & Lomb and helped move us toward a stronger global organization,” stated Hassan. “Now we will be initiating a new phase to take Bausch & Lomb to an even higher level of performance. I look forward to my role as chairman of an active and engaged board of directors, working closely with and supporting our new CEO Brent Saunders.”
Professional Therapy MuscleCare launches topical pain relievers
NEW YORK Professional Therapy MuscleCare on Monday announced the launch of a line of topical analgesics into the mass channels with distribution deals inked for Duane Reade, CVS.com and Amazon.com.
The initial launch include two topical analgesics — topical Professional Therapy MuscleCare extra-strength roll-on gel and Professional Therapy MuscleCare ointment — provide long-lasting, all-natural relief from pain, both acute and chronic muscle injury strains/spasm, and joint arthritis. The products contain camphor and menthol to relax tissue, increase the flow of healthy blood and nutrients in order to reset the muscle to its normal resting length and promote healing.
“The topical pain relief industry has long been lacking in safety and efficacy, and I have gone to great lengths and conducted a thorough clinical study to change that,” stated Chris Oswald, CEO of Professional Therapy MuscleCare.
The retail price is $19.99 for the roll-on gel and $25.99 for the ointment.